Why the study?
Data on incident AF following diagnosis, associated risk factors, and its prognostic impact in patients with wild-type transthyretin amyloidosis remain limited.
Population
208 patients with ATTRwt diagnosed between 2016 and 2022
Comparison
Presence or development of AF vs no AF
Design
Single-centre cohort study
Follow-up
Three years
Authors
Loading...
New AF in ATTRwt may indicate higher mortality; leaves open whether screening or intervention improves outcomes.
Atrial fibrillation is highly prevalent and frequently develops in patients with wild-type transthyretin amyloidosis, with higher BMI, disease stage, and left ventricular mass index predicting new-onset AF.
Skov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: